Search

Search Constraints

You searched for: Author/Creator Lee, L.H.

Search Results

1. 201P Phase II study of taminadenant (A2AR antagonist) + spartalizumab (anti PD-1 antibody) in patients with triple-negative breast cancer (TNBC). (December 2022)